Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Cost-effectiveness of pneumococcal and influenza vaccination standing order programs.

Lin CJ, Zimmerman RK, Smith KJ.

Am J Manag Care. 2013 Jan 1;19(1):e30-7.

2.

Cost effectiveness of pneumococcal conjugate vaccination against acute otitis media in children: a review.

Boonacker CW, Broos PH, Sanders EA, Schilder AG, Rovers MM.

Pharmacoeconomics. 2011 Mar;29(3):199-211. doi: 10.2165/11584930-000000000-00000. Review.

PMID:
21250759
3.

The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine.

Isaacman DJ, Strutton DR, Kalpas EA, Horowicz-Mehler N, Stern LS, Casciano R, Ciuryla V.

Clin Ther. 2008 Feb;30(2):341-57. doi: 10.1016/j.clinthera.2008.02.003. Review.

PMID:
18343273
4.

Influenza vaccination health impact and cost effectiveness among adults aged 50 to 64 and 65 and older.

Maciosek MV, Solberg LI, Coffield AB, Edwards NM, Goodman MJ.

Am J Prev Med. 2006 Jul;31(1):72-9. Review.

PMID:
16777545
5.

Seasonal influenza vaccination of healthy working-age adults: a review of economic evaluations.

Gatwood J, Meltzer MI, Messonnier M, Ortega-Sanchez IR, Balkrishnan R, Prosser LA.

Drugs. 2012 Jan 1;72(1):35-48. doi: 10.2165/11597310-000000000-00000. Review.

PMID:
22191794

Supplemental Content

Write to the Help Desk